2028
Y.-Y. Han et al. / Tetrahedron Letters 51 (2010) 2023–2028
Weinheim; (c) Katrizky, A. R.; Pozharskii, A. F. Handbook of Heterocyclic
Chemistry, second ed.; Pergamon: Amsterdam, 2000.
7. (a) Olah, G. A.. In Friedel–Crafts and Related Reactions; Interscience: New York,
1964; Vol. III. Part 1; (b) Heaney, H. In Comprehensive Organic Synthesis; Trost, B.
M., Ed.; Pergamon Press: New York, 1991.
2. (a) Vega, A. M.; Gil, M. J.; Basilio, A.; Giraldez, A.; Fernandez-Alvarez, E. Eur. J.
Med. Chem. 1986, 21, 251–254; (b) Manca, P.; Peana, A.; Savelli, F.; Mulé, A.;
Pirisino, G. Farmaco 1992, 47, 519–522.
3. (a) Loriga, M.; Fiore, M.; Sannaand, P.; Paglietti, G. Farmaco 1995, 50, 289–301;
(b) Epperson, J. R.; Hewawasam, P.; Meanwell, N. A.; Boissard, C. G.; Gribkoff, V.
K.; Post-Munson, D. Bioorg. Med. Chem. Lett. 1993, 3, 2801–2804; (c) McQuaid,
L. A.; Smith, E. C. R.; South, K. K.; Mitch, C. H.; Schoepp, D. D.; True, R. A.;
Calligaro, D. O.; O’Malley, P. J.; Lodge, D.; Ornstein, P. L. J. Med. Chem. 1992, 35,
3319–3324.
4. (a) Heldin, C. H.; Westermark, B.; Wasteson, A. Proc. Natl. Acad. Sci. U.S.A. 1979,
76, 3722–3726; (b) Heldin, C. H.; Westermark, B. Cell Regul. 1990, 1, 555–566;
(c) Heldin, C. H. EMBO J. 1992, 11, 4251–4259; (d) Myers, M. R.; He, W.; Hanney,
B.; Setzer, N.; Maguire, M. P.; Zulli, A.; Bilder, G.; Galzcinski, H.; Amin, D.;
Needle, S.; Spada, A. P. Bioorg. Med. Chem. Lett. 2003, 13, 3091–3095; (e) He, W.;
Myers, M. R.; Hanney, B.; Spada, A. P.; Bilder, G.; Galzcinski, H.; Amin, D.;
Needle, S.; Page, K.; Jayyosi, Z.; Perrone, M. H. Bioorg. Med. Chem. Lett. 2003, 13,
3097–3100; (f) Gazit, A.; Yee, K.; Uecker, A.; Bohmer, F. D.; Sjoblom, T.; Ostman,
A.; Waltenberger, J.; Golomb, G.; Banai, S.; Heinrich, M. C.; Levitzki, A. Bioorg.
Med. Chem. 2003, 11, 2007–2018.
5. (a) Aoki, K.; Obata, T.; Yamazaki, Y.; Mori, Y.; Hirokawa, H.; Koseki, J.; Hattori,
T.; Niitsu, K.; Takeda, S.; Aburada, M.; Miyamoto, K. Chem. Pharm. Bull. 2007, 55,
255–267; (b) Aoki, K.; Koseki, J.; Takeda, S.; Aburada, M.; Miyamoto, K. Chem.
Pharm. Bull. 2007, 55, 922–925.
6. (a) Bergstrand, H.; Karabelas, K.; Sjo, P. PCT Int. WO9813368 A1 19980402
(1998).; (b) Karabelas, K.; Lonn, H., Sjo, P. PCT Int. Appl. WO9946260 A1
19990916 (1999).; (c) Karabelas, K.; Sjo, P. PCT Int. WO9946264 A1 19990916
(1999).; (d) Nixey, T.; Temperst, P.; Hulme, C. Tetrahedron Lett. 2002, 43, 1637–
1639; (e) Chupakhin, O. N.; Sidorov, E. O.; Postovskii, I. Y. Khimiya
Geterotsiklicheskikh Soedinenii 1975, 10, 1433–1434.
8. For selected examples, see: (a) Johannsen, M. Chem. Commun. 1999, 2233–
2234; (b) Janczuk, A.; Zhang, W.; Xie, W. H.; Lou, S. Z.; Cheng, J. P.; Wang, P. G.
Tetrahedron Lett. 2002, 43, 4271–4274; (c) Endo, A.; Yanagisawa, A.; Abe, M.;
Tohma, S.; Kan, T.; Fukuyama, T. J. Am. Chem. Soc. 2002, 124, 6552–6554; (d) Lei,
F.; Chen, Y.-J.; Sui, Y.; Liu, L.; Wang, D. Synlett 2003, 1160–1164.
9. (a) Bergman, J.; Venemalm, L. J. Org. Chem. 1992, 57, 2495–2497; (b) Lakhdar,
S.; Westermaier, M.; Terrier, F.; Goumont, R.; Boubaker, T.; Ofial, A. R.; Mayr, H.
J. Org. Chem. 2006, 71, 9088–9095; (c) Tsuchimoto, T.; Matsubayashi, H.;
Kaneko, M.; Nagase, Y.; Miyamura, T.; Shirakawa, E. J. Am. Chem. Soc. 2008, 130,
15823–15835.
10. Various quinoxalin-2-ones were prepared according to the reported procedure,
see: McAtee, J. J.; Dodson, J. W.; Dowdell, S. E.; Girard, G. R.; Goodman, K. B.;
Hilfiker, M. A.; Sehon, C. A.; Sha, D.; Wang, G. Z.; Wang, N.; Viet, A. Q.; Zhang,
D.; Aiyar, N. V.; Behm, D. J.; Carballo, L. H.; Evans, C. A.; Fries, H. E.; Nagilla, R.;
Roethke, T. J.; Xu, X.; Yuan, C. C. K.; Douglas, S. A.; Neeb, M. J. Bioorg. Med. Chem.
Lett. 2008, 18, 3500–3503.
11. Using DMSO, toluene, EtOAc, CH2Cl2, THF, and CH3OH as solvents, respectively,
only trace amount of the corresponding product was monitored by thin layer
chromatography (TLC).
12. DABCO = 1,4-diazabicyclo[2.2.2]octane, DBU = 1,8-diazabicyclo[5.4.0]undec-7-
ene.
13. The corresponding N-benzyl intermediate
B was successfully isolated
and was ascertained by 1H NMR and 13C NMR spectra (See Supplementary
data).
14. In this verification experiment, the reaction was run with the amount 1a/2a/
5 = 0.4 mmol/0.8 mmol/0.5 mmol in 1.0 mL DMF.